Dr. David Spigel on the Utility of Molecular Marker Results in the Adjuvant Setting for Early Stage Non-Small Cell Lung Cancer

10 apr 2013 · 1 min. 44 sec.

Descrizione

Dr. David Spigel addresses the question of whether to obtain molecular marker results in patients with early stage lung cancer and what to do with that information if it is...

mostra di più

Dr. David Spigel addresses the question of whether to obtain molecular marker results in patients with early stage lung cancer and what to do with that information if it is available for potential application in the adjuvant setting.

mostra meno

Commenti

Accedi per lasciare un commento

Informazioni

Autore	cancerGRACE
Organizzazione	cancerGRACE
Sito	-
Tag	#adjuvant #alk #cancer #cancergrace #cannon #center #david #egfr #grace #gracecast #molecular #mutation #oncology #postoperative #rearrangement #sarah #spigel #targeted #therapy #treatment